BMO Capital Downgrades Exelon to Market Perform, Lowers Price Target to $49

Benzinga Newsdesk www.benzinga.com Negative 91.2%

Neg 91.2% Neu 0% Pos 0%

BMO Capital analyst James Thalacker downgrades Exelon (NASDAQ:EXC) from Outperform to Market Perform and lowers the price target from $52 to $49.